Evaluation of the Reproducibility of the Automated Measurement of the Extent of ILD on Chest CT (REPRO-PID)

Assistance Publique - Hôpitaux de Paris

Status: Enrolling

Conditions: Interstitial Lung Disease

Treatments: Diagnostic Test: Chest CT

Study type: Interventional

Funder types: Other

Identifiers

NCT06743022

APHP240783

2024-A01384-43 (Other Identifier)

Details and patient eligibility

About

In interstitial lung disease (ILD), the extent of ILD on chest computed tomography (CT) is recognized as an important prognostic factor. Automated tools are now available to quantify ILD, but there is a lack of data on the reproducibility of this measurement and therefore its accuracy.

Therefore, the purpose of this study is to evaluate the variability of automated ILD quantification on chest CT. Reproducibility will be assessed by repeating chest CT scans and using different tools to measure the extent of disease.

Full description

In interstitial lung disease (ILD), the extent of ILD on chest computed tomography (CT) is recognized as an important prognostic factor. In recent years, several tools based on texture analysis or deep learning methods have been developed to provide rapid and accurate automated quantification of ILD extent.

An advantage of automated scoring methods is that they theoretically offer perfect repeatability of measurement. However, this is only true if the measurement is repeated on the same images. Several parameters can alter the appearance of the lungs on scanner images, such as the degree of inspiration or the reconstruction kernel used to reconstruct the images. There is a lack of data on the reproducibility of the whole process of automated ILD quantification and therefore its accuracy.

Therefore, the purpose of this study is to evaluate the variability of automated ILD quantification on chest CT.

Reproducibility will be assessed by repeating chest CT scans and using different tools to measure the extent of disease in patients with ILD from 2 institutions. Chest CT will be repeated the same day. This will allow assessment of the variability of automated measurement of ILD extent between 2 CT scans performed on the same day and when using different software. It will also allow to assess the variability of lung volume between the 2 CT scans and the effect of disease (idiopathic pulmonary fibrosis or connective tissue disease-related ILD) on the reproducibility of ILD quantification.

Enrollment: 150 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age ≥ 18 years
• Known interstitial lung disease as part of idiopathic pulmonary fibrosis or connective tissue disease
• Followed in one of the participating hospitals
• Requiring a chest CT as part of a scheduled assessment
• Affiliated to a French national social security
• Informed consent

Exclusion criteria

• Acute exacerbation of ILD
• Pregnancy
• Inability to hold an apnea for 10 seconds
• Patients in the exclusion period after a previous research
• Need for additional procubitus or expiratory images

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

150 participants in 1 patient group

Patients with interstitial lung disease

Experimental group

Treatment:

Diagnostic Test: Chest CT